HUMAN RIGHTS AND PUBLIC HEALTH

In a free, open society, every individual should be free to follow his own conscience and to decide how he governs his consciousness, as long as this harms no others. For millions of people using psychedelics and MDMA, this is important for their lives in personal, spiritual and cultural ways. The right to pursue such a living therefore must be protected.

«Many resourceful people view MDMA and psychedelics as sensible options to alcohol. Not surprisingly, as leading science on the field indicates psychedelics and MDMA to be far less harmful than alcohol»
— Frode Andre V. Myhre (Leader, EmmaSofia Student Association in Trondheim) “MDMA is a sensible option to alcohol”, Adressa (newspaper), March 2016

RISK PROFILE

The pursuit of happiness, self-understanding and joy are fundamental human goals. For years the UN has recognized that for many people, using psychedelics is a part of a genuine spiritual practice, comparable to meditation and yoga. Furthermore psychedelics show promise in treating a wide range of medical conditions.

There is wide scientific consensus that psychedelics and MDMA are far less harmful to individuals and to society when compared with alcohol. In the Netherlands, hundreds of thousands of psychedelic mushrooms (psilocybin) are sold legally every year. Dutch health authorities and law enforcement both agree there are few problems connected with the use of psychedelic mushrooms.

 

.

Use of psychedelic mushrooms (legally sold in the Netherlands) makes up such little risk to individuals and society, that prohibition and punishment would be a disproportionately severe sanction.
— The Netherlands’ official risk assessment, CAM 2007.

It is important to emphasize a statistical perspective on risk, rather than worst-case scenarios which are few and far between. Nothing is risk-free, including psychedelics and MDMA. But by putting risk in perspective, considering the millions of doses consumed every year, psychedelics and MDMA do not appear particularly risky, comparing to activities considered relatively harmless (such as various sports).

 

The ban deals society more harm than what it prevents.
— Report from the UN special envoy for the right to health, 2010.

The ban on psychedelics, MDMA and other drugs is supposed to be a public health measure, but the ban is based neither on a risk assessment nor a cost-benefit analysis.

 

Today’s policies are justified only if they prevent more harm than they cause.

— Jørn Kløvfjell Mjelva (Leader, EmmaSofia Student Association), VG, 27th June 2014.

The World Health Organization (WHO) is through international treaties (Convention of Psychotropic Substances, 1971) given special responsibility to prove that a ban on personal use of certain drugs is a good public health measure. This has never been the case with psychedelics or MDMA.

There are no data available data regarding MDMAs potential for abuse, public health or social problems. World Health Organization assessment of MDMA, WHO TRS 729, 1985. The ban seems to be anchored in fear, outdated policies and prejudices rather than science.
— World Health Organization assessment of MDMA, WHO TRS 729, 1985.

This prohibition appears to be rooted in fear, an outdated policy and prejudices, rather than documentation.

WHO could not cite a single example on naturally occuring psychedelics such as psilocybin or peyote to be harmful. In the consideration, only a handful of LSD-related anectodes were raised. This was in no way an evidence-based risk assessment.
— Teri Krebs (Board Leader, EmmaSofia) “Protecting the human rights of people who use psychedelics”, Lancet Psychiatry, April 2015.

QUALITY CONTROLLED PRODUCTION

Quality controlled production and correct labelling are fundamental principles for modern consumer goods (such as medicines and foods). People have been harmed and killed after use of false or contaminated MDMA, psychedelic mushrooms and LSD. To ban quality control of MDMA and psychedelics is irresponsible, from a public health and ethical perspective.

Legal regulation protects public health. Consumers need awareness of what they consume, and they need clear information on potential risks and how to minimize these. Legal regulation should be based on scientce and a genuine interest for public health and human rights.
— Kofi Annan (Former UN General Secretary), World Health Gathering, may 2015

It is legal to produce MDMA and psychedelics in Norway as long as all necessary permits for production and storage are granted.

EmmaSofia has a deal with a pharmaceutical company regarding production of MDMA and psilocybin for treatment, research and other legal purposes.


Licensed producers can make drugs listed on the Norwegian list of illegal drugs. This applies also to MDMA and psychedelics. Such drugs are legal to use for medical treatment and research according to the law on medicines, § 23. Drugs without marketing permission can, after an application process, also be used legally in Norway.
— Ketil Lund (former Norwegian supreme court justice) and Hans Fredrik Marthinussen (professor, Faculty of Law, University of Bergen) / legal advisors for EmmaSofia.

TAKING PRECAUTIONS

Compared to legal drugs, psychedelics and MDMA are not particularly dangerous. Under today’s ban however, these drugs are traded without regulation. Thus there is no quality control or age limits. As a temporary public health measure, we encourage use of test kits for people deciding to use psychedelics or MDMA.

Tes-kits are easily available online. Be moderate with dosage, and do not combine with other drugs like alcohol. Contact a physician if you feel ill. One should never be under the influence of any drugs, neither psychedelics and MDMA nor alcohol, during activities like driving or caring for children.

In repeated expert opinions, two of which are published in the Lancet, researchers have assessed the risk potential for a range of drugs. The assessment finds MDMA and psychedelics less harmful than legal drugs such as alcohol and nicotine.

 

 

A GROWING MOVEMENT

In Norway, 80 000 people have experience with MDMA, 50 000 with LSD, and tens of thousands have experienced psychedelic mushrooms, mescaline and ayahuasca (SIRUS investigation 2013).

 

You should not be so tolerant of the injustice not done to you.
— Arnulf Øverland

People in Norway and the world at large should feel safe and free to express their opinion on MDMA and psychedelics. Do you wish to contribute making Norway into a place for evidence-based drug policies we know work? Then you should support EmmaSofia by becoming a member. Memberships are anonymous.

 

Together we will make a more open and tolerant society.